Sakr Rita A, Schizas Michail, Carniello Jose V Scarpa, Ng Charlotte K Y, Piscuoglio Salvatore, Giri Dilip, Andrade Victor P, De Brot Marina, Lim Raymond S, Towers Russell, Weigelt Britta, Reis-Filho Jorge S, King Tari A
Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
Mol Oncol. 2016 Feb;10(2):360-70. doi: 10.1016/j.molonc.2015.11.001. Epub 2015 Nov 14.
Lobular carcinoma in situ (LCIS) has been proposed as a non-obligate precursor of invasive lobular carcinoma (ILC). Here we sought to define the repertoire of somatic genetic alterations in pure LCIS and in synchronous LCIS and ILC using targeted massively parallel sequencing.
DNA samples extracted from microdissected LCIS, ILC and matched normal breast tissue or peripheral blood from 30 patients were subjected to massively parallel sequencing targeting all exons of 273 genes, including the genes most frequently mutated in breast cancer and DNA repair-related genes. Single nucleotide variants and insertions and deletions were identified using state-of-the-art bioinformatics approaches.
The constellation of somatic mutations found in LCIS (n = 34) and ILC (n = 21) were similar, with the most frequently mutated genes being CDH1 (56% and 66%, respectively), PIK3CA (41% and 52%, respectively) and CBFB (12% and 19%, respectively). Among 19 LCIS and ILC synchronous pairs, 14 (74%) had at least one identical mutation in common, including identical PIK3CA and CDH1 mutations. Paired analysis of independent foci of LCIS from 3 breasts revealed at least one common mutation in each of the 3 pairs (CDH1, PIK3CA, CBFB and PKHD1L1).
LCIS and ILC have a similar repertoire of somatic mutations, with PIK3CA and CDH1 being the most frequently mutated genes. The presence of identical mutations between LCIS-LCIS and LCIS-ILC pairs demonstrates that LCIS is a clonal neoplastic lesion, and provides additional evidence that at least some LCIS are non-obligate precursors of ILC.
小叶原位癌(LCIS)被认为是浸润性小叶癌(ILC)的非必然前体。在此,我们试图通过靶向大规模平行测序来确定纯LCIS以及同步发生的LCIS和ILC中的体细胞基因改变情况。
从30例患者的显微切割的LCIS、ILC以及匹配的正常乳腺组织或外周血中提取的DNA样本,进行针对273个基因所有外显子的大规模平行测序,这些基因包括乳腺癌中最常发生突变的基因以及与DNA修复相关的基因。使用最先进的生物信息学方法鉴定单核苷酸变异以及插入和缺失。
在LCIS(n = 34)和ILC(n = 21)中发现的体细胞突变情况相似,最常发生突变的基因分别是CDH1(分别为56%和66%)、PIK3CA(分别为41%和52%)和CBFB(分别为12%和19%)。在19对同步发生的LCIS和ILC中,14对(74%)至少有一个相同的突变,包括相同的PIK3CA和CDH1突变。对来自3例乳腺的LCIS独立病灶进行配对分析,发现3对中的每一对都至少有一个共同突变(CDH1、PIK3CA、CBFB和PKHD1L1)。
LCIS和ILC具有相似的体细胞突变情况,PIK3CA和CDH1是最常发生突变的基因。LCIS-LCIS对和LCIS-ILC对之间存在相同突变,表明LCIS是一种克隆性肿瘤性病变,并提供了额外证据,证明至少一些LCIS是ILC的非必然前体。